Orthofix Medical (OFIX) Depreciation & Amortization (CF) (2016 - 2026)
Orthofix Medical has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $13.5 million for Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 60.81% year-over-year to $13.5 million, compared with a TTM value of $56.4 million through Mar 2026, down 29.19%, and an annual FY2025 reading of $77.3 million, up 28.74% over the prior year.
- Depreciation & Amortization (CF) came in at $13.5 million for Q1 2026, up from $13.1 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $34.4 million in Q1 2025 to a low of $6.5 million in Q2 2022.
- Median Depreciation & Amortization (CF) over the past 5 years was $13.3 million (2023), compared with a mean of $13.7 million.
- The sharpest move saw Depreciation & Amortization (CF) soared 131.67% in 2025, then plummeted 60.81% in 2026.
- Over 5 years, Depreciation & Amortization (CF) stood at $7.4 million in 2022, then soared by 88.24% to $14.0 million in 2023, then increased by 14.5% to $16.0 million in 2024, then decreased by 18.23% to $13.1 million in 2025, then increased by 3.17% to $13.5 million in 2026.
- Per Business Quant, the three most recent readings for OFIX's Depreciation & Amortization (CF) are $13.5 million (Q1 2026), $13.1 million (Q4 2025), and $12.9 million (Q3 2025).